Premium
Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/sezary syndrome
Author(s) -
Calderon Cabrera Cristina,
de la Cruz Vicente Fatima,
MarínNiebla Ana,
Carrillo Cruz Estrella,
Rios Herranz Eduardo,
Espigado Tocino Ildefonso,
Prats Martín Concepción,
Falantes Jose F.,
Martino Galiana María L.,
PerezSimón Jose A.
Publication year - 2013
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12320
Subject(s) - bexarotene , mycosis fungoides , pentostatin , medicine , cutaneous t cell lymphoma , cyclophosphamide , stage (stratigraphy) , chemotherapy , oncology , dermatology , lymphoma , biology , rituximab , biochemistry , nuclear receptor , transcription factor , gene , paleontology